Baird analyst Eric Coldwell designated McKesson (MCK) as a Bullish Fresh Pick. Baird maintains its Outperform rating and $730 price target on ...

Buying $100 In MCK: If an investor had bought $100 of MCK stock 5 years ago, it would be worth $347.63 today based on a price ...

According to Benzinga Pro, McKesson's peer group average for short interest as a percentage of float is 4.71%, which means ...

StockNews.com cut shares of McKesson (NYSE:MCK – Free Report) from a strong-buy rating to a buy rating in a report released on Friday. MCK has been the topic of a number of other research reports.

The Janus Henderson Global Sustainable Equity Managed Account Portfolio returned -5.71% (gross) for Q4 2024. Click here to ...

Project GOLD is a first-of-its-kind resiliency collaboration in the U.S., uniquely designed to address drug shortages in the oncology sector. At launch, Project GOLD has already achieved three ...

The Trump administration’s moves to trim government spending pose a short-term “understated risk” for companies all across ...

Medtech companies have their eye on the growing hospital-at-home market, which is driven largely by the rising elderly ...

SEOUL, South Korea, Feb. 13, 2025 /CNW/ -- Hanmi Pharmaceutical's Global Business Headquarters Overseas Sales Team is making ...

Shares of McKesson Corp. MCK shed 2.52% to $595.00 Wednesday, on what proved to be an all-around poor trading session for the ...